FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2809409035> ?p ?o ?g. }

• W2809409035 endingPage "28455" @default.
• W2809409035 startingPage "28445" @default.
• W2809409035 abstract "Angiogenesis is essential for colorectal cancer (CRC) progression, as demonstrated by the beneficial clinical effects of therapeutics inhibiting VEGF signaling. However, alternative mechanisms of neovascularization can develop, resulting in treatment failure. Previously we demonstrated NF-κB-inducing kinase (NIK) contributes to pathological angiogenesis. Here, we investigate NIK as a therapeutic target in endothelial cells (EC) in CRC. To determine NIK expression levels in CRC tissues, we immunostained both primary colorectal tumors and tumors metastasized to the liver. Additionally, a 3D tumor-stromal cell interaction model was developed including EC, fibroblasts and CRC cells to study tumor angiogenesis. This model tested efficacy of NIK-targeting siRNA (siNIK) in EC alone or in combination with the anti-VEGF antibody, bevacizumab. Both primary CRC and liver metastases contained blood vessels expressing NIK. In patients receiving chemotherapy plus bevacizumab, immature NIK+ vessels (p < 0.05) were increased as compared to chemotherapy alone. Activation of NIK by lymphotoxin-beta receptor (LTβR) induced increases in pro-angiogenic mediators, including interleukin (IL)-6, IL-8, chemokine (C-X-C motif) ligand (CXCL)1 and CXCL5 in EC and fibroblasts, accompanied by sprouting in the 3D model, which was blocked by siNIK in EC. Treatment with bevacizumab plus siNIK in EC resulted in a synergistic effect and reduced VEGF and bFGF-induced sprouting (p < 0.05). Here, we demonstrate a role for NIK in CRC-associated angiogenesis. Targeting NIK in EC in combination with anti-VEGF antibody bevacizumab may hold therapeutic potential to increase efficiency in blocking tumor neovascularization, either to prevent treatment failure due to activation of accessory pathways such as NF-κB signaling or as a rescue treatment." @default.
• W2809409035 created "2018-06-29" @default.
• W2809409035 creator A5027180965 @default.
• W2809409035 creator A5031748554 @default.
• W2809409035 creator A5033553571 @default.
• W2809409035 creator A5049654634 @default.
• W2809409035 creator A5052059898 @default.
• W2809409035 creator A5054799488 @default.
• W2809409035 creator A5088821276 @default.
• W2809409035 date "2018-06-19" @default.
• W2809409035 modified "2023-09-24" @default.
• W2809409035 title "Silencing NIK potentiates anti-VEGF therapy in a novel 3D model of colorectal cancer angiogenesis" @default.
• W2809409035 cites W1505106591 @default.
• W2809409035 cites W1533021978 @default.
• W2809409035 cites W1879988417 @default.
• W2809409035 cites W1968703569 @default.
• W2809409035 cites W1971828920 @default.
• W2809409035 cites W1978148288 @default.
• W2809409035 cites W2007456673 @default.
• W2809409035 cites W2012034410 @default.
• W2809409035 cites W2015414283 @default.
• W2809409035 cites W2017322644 @default.
• W2809409035 cites W2021996780 @default.
• W2809409035 cites W2042276775 @default.
• W2809409035 cites W2051433588 @default.
• W2809409035 cites W2058516219 @default.
• W2809409035 cites W2086619383 @default.
• W2809409035 cites W2100077844 @default.
• W2809409035 cites W2138560890 @default.
• W2809409035 cites W2158293515 @default.
• W2809409035 cites W2174540735 @default.
• W2809409035 cites W2285354269 @default.
• W2809409035 cites W2315613727 @default.
• W2809409035 cites W2550194484 @default.
• W2809409035 cites W2591153018 @default.
• W2809409035 cites W2608668548 @default.
• W2809409035 cites W2620769476 @default.
• W2809409035 cites W2649656222 @default.
• W2809409035 cites W2719499442 @default.
• W2809409035 cites W2727408825 @default.
• W2809409035 cites W2746753053 @default.
• W2809409035 cites W4211001330 @default.
• W2809409035 cites W4211214747 @default.
• W2809409035 cites W4250428608 @default.
• W2809409035 doi "https://doi.org/10.18632/oncotarget.25442" @default.
• W2809409035 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6033358" @default.
• W2809409035 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29983872" @default.
• W2809409035 hasPublicationYear "2018" @default.
• W2809409035 type Work @default.
• W2809409035 sameAs 2809409035 @default.
• W2809409035 citedByCount "6" @default.
• W2809409035 countsByYear W28094090352019 @default.
• W2809409035 countsByYear W28094090352020 @default.
• W2809409035 countsByYear W28094090352022 @default.
• W2809409035 countsByYear W28094090352023 @default.
• W2809409035 crossrefType "journal-article" @default.
• W2809409035 hasAuthorship W2809409035A5027180965 @default.
• W2809409035 hasAuthorship W2809409035A5031748554 @default.
• W2809409035 hasAuthorship W2809409035A5033553571 @default.
• W2809409035 hasAuthorship W2809409035A5049654634 @default.
• W2809409035 hasAuthorship W2809409035A5052059898 @default.
• W2809409035 hasAuthorship W2809409035A5054799488 @default.
• W2809409035 hasAuthorship W2809409035A5088821276 @default.
• W2809409035 hasBestOaLocation W28094090351 @default.
• W2809409035 hasConcept C104317684 @default.
• W2809409035 hasConcept C119056186 @default.
• W2809409035 hasConcept C121608353 @default.
• W2809409035 hasConcept C126322002 @default.
• W2809409035 hasConcept C13373296 @default.
• W2809409035 hasConcept C167734588 @default.
• W2809409035 hasConcept C203014093 @default.
• W2809409035 hasConcept C2776694085 @default.
• W2809409035 hasConcept C2776914184 @default.
• W2809409035 hasConcept C2777025900 @default.
• W2809409035 hasConcept C2777802072 @default.
• W2809409035 hasConcept C2778271429 @default.
• W2809409035 hasConcept C2780394083 @default.
• W2809409035 hasConcept C502942594 @default.
• W2809409035 hasConcept C526805850 @default.
• W2809409035 hasConcept C55493867 @default.
• W2809409035 hasConcept C71924100 @default.
• W2809409035 hasConcept C86803240 @default.
• W2809409035 hasConceptScore W2809409035C104317684 @default.
• W2809409035 hasConceptScore W2809409035C119056186 @default.
• W2809409035 hasConceptScore W2809409035C121608353 @default.
• W2809409035 hasConceptScore W2809409035C126322002 @default.
• W2809409035 hasConceptScore W2809409035C13373296 @default.
• W2809409035 hasConceptScore W2809409035C167734588 @default.
• W2809409035 hasConceptScore W2809409035C203014093 @default.
• W2809409035 hasConceptScore W2809409035C2776694085 @default.
• W2809409035 hasConceptScore W2809409035C2776914184 @default.
• W2809409035 hasConceptScore W2809409035C2777025900 @default.
• W2809409035 hasConceptScore W2809409035C2777802072 @default.
• W2809409035 hasConceptScore W2809409035C2778271429 @default.
• W2809409035 hasConceptScore W2809409035C2780394083 @default.
• W2809409035 hasConceptScore W2809409035C502942594 @default.
• W2809409035 hasConceptScore W2809409035C526805850 @default.
• W2809409035 hasConceptScore W2809409035C55493867 @default.

• next